TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04760054

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HUBOD
Description: Participants in the intervention group will attend 5 separate training sessions instructing them in Hubod. The Hubod exercise is a partnered coordination drill involving moves derived from numerous martial arts, most often seen in the Filipino martial art of Kali. Participants will aim to reach a level of comfort and competency in the basic, non-competitive aspects of the Hubod exercise by the end of their participation in this intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Participants in the active comparator group will attend 5 separate training sessions. Each session will involve a 5 minute warmup of joint mobilization exercises and mild pedaling on the bicycle before the main effort of continuously using the bicycle for approximately 20 minutes. The session finishes with a 5 minute cooldown period and light stretch. Heartrate will be monitored regularly in order to prevent this exercise exceeding the relative intensity of the Martial Arts intervention group. Participants will be allowed to talk and interact with research assistants in order to keep socialization effects consistent across groups.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control Condition
Description: Participants in this group will attend 5 separate training sessions. Each session will involve watching educational videos on martial arts techniques and training methods from a sedentary position. Participants will be allowed to talk and interact with research assistants in order to keep socialization effects consistent across groups.
Study: NCT06598176

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colli-Pee 20mL device with UCM
Description: Women will collect a first-void urine (the initial part of the urine stream) sample at home the day before a hospital appointment using the 20mL Colli-Pee device prefilled with urine conservation medium (UCM, Novosanis, Belgium).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Evalyn Brush
Description: Women will collect a vaginal self-sample using the Evalyn Brush (Rovers Medical Devices, The Netherlands) at home the day before a hospital appointment.
Study: NCT06592066

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital Impression by using Intraoral Scanning of Scan Bodies
Description: intraoral scanning will be used to capture the positions of full-arch mandibular implants with the aid of scan bodies.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital Impression by using Intraoral Scanning of Scan Bodies with Prefabricated Landmarks
Description: intraoral scanning will be used to capture the positions of full-arch mandibular implants with the aid of scan bodies with prefabricated landmarks in place.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Splinted Open Top Tay Conventional Impression Technique
Description: Splinted open-top tray conventional impression technique will be preformed by using medium body silicone impression material.
Study: NCT06591416

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: minimally invasive surgical technique
Description: minimally invasive surgical technique

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: minimally invasive surgical technique with granulation tissue preservation
Description: minimally invasive surgical technique with granulation tissue preservation
Study: NCT06586177

Intervention type: DRUG
Intervention: Anti-CD20 antibody
Description: Study participants receive an anti-CD20 antibody according to the summary of product characteristics.

Intervention type: DRUG
Intervention: Anti-CD20 antibody
Description: Study participants receive an anti-CD20 antibody according to the summary of product characteristics.
Study: NCT06053671

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Blood and nasal swab sampling
Description: Genetic screening of DNA samples (blood, mucosal swab, brain tissue) from 60-100 patients with histologically confirmed diagnosis of FCDIIA/B identified from Epilepsy Surgery Databases.
Study: NCT06587087

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smartest-AE: The lancet that will be used will be the Vitrex Soft Lite lll 28G.
Description: The lancet that will be used for all subjects will be the Vitrex Soft Lite lll 28G.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartest-AE: The lancet that will be used will be the Vitrex Soft Lite lll 28G.
Description: The lancet that will be used for all subjects will be the Vitrex Soft Lite lll 28G.
Study: NCT06600256

Intervention type: BEHAVIORAL
Intervention: Viz HCM ECG Review
Description: Viz HCM will auto-alert relevant users to ECGs the algorithm has deemed as suspicious for HCM. Following review of this alert and the patient\&amp;#39;s Medical/Clinical History, the reviewer will take the next Standard of Care action they deem appropriate.

Intervention type: BEHAVIORAL
Intervention: Baseline Effectiveness Cohort
Description: A review of the timing and clinical details of the diagnostic process for patients diagnosed with HCM before the site began using Viz HCM.
Study: NCT05854368

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Additional blood collection as part of routine care
Description: Collection of an additional blood volume (10mL) as part of a blood sampling performed during routine care or specific for the research if not part of routine care.
Study: NCT05053425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: given po.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: given sc.
Study: NCT05854368

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood collection
Description: Blood sample collection (10 mL)
Study: NCT06497270

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Theca and Granulosa Cell Isolation
Description: These patients will receive standard procedure during the risk reducing surgery but their ovaries will be used to extract theca and granulosa cells which will be used for the 3D bioprinted device's realisation.
Study: NCT04994509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lenacapavir (LEN)
Description: Tablets administered orally without regard to food

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lenacapavir (LEN)
Description: Tablets administered orally without regard to food

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lenacapavir (LEN)
Description: Tablets administered orally without regard to food

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) Lenacapavir (LEN)
Description: Administered via SC injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) Lenacapavir (LEN)
Description: Administered via SC injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) Lenacapavir (LEN)
Description: Administered via SC injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF
Description: Tablets administered orally
Study: NCT05053425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cladribine
Description: given ivgtt.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: given sc or ivgtt.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: given ivgtt.
Study: NCT04994509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TDF
Description: Tablets administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TDF
Description: Tablets administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo SC LEN
Description: Administered via SC injections
Study: NCT05399121

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Piano Learning then Free Improvisation
Description: During all 15 sessions (one session per patient) all patients will be asked to perform two piano playing exercises:~Exercise 1 - Piano Learning exercise - The music therapist will guide the patient to use separate finger movement and to play a brief extract from a familiar song. The therapist guiding techniques may include (but not restricted to) demonstrating to the patient which keys to press (turn- taking), playing the same notes with them in synchronization, or harmonizing the patient's playing.~The patient will then be asked to perform exercise 2. Exercise 2: Free Improvisation exercise -The patient will be instructed to use separate finger movement while playing freely on the piano while the therapist musically. The therapist will use various MT accompaniment techniques.~Both exercises will be performed for the same amount of time (5 minutes each).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Free Improvisation then Piano Learning
Description: During all 15 sessions (one session per patient) all patients will be asked to perform two piano playing exercises:~Exercise 1: Free Improvisation exercise -The patient will be instructed to use separate finger movement while playing freely on the piano while the therapist musically interacts with them. The therapist will use various MT accompaniment techniques.~The patient will then be asked to perform exercise 2. Exercise 2 - Piano Learning exercise - The music therapist will guide the patient to use separate finger movement and to play a brief extract from a familiar song. The therapist guiding techniques may include (but not restricted to) demonstrating to the patient which keys to press (turn- taking), playing the same notes with them in synchronization, or harmonizing the patient's playing.~Both exercises will be performed for the same amount of time (5 minutes each).
Study: NCT05300269

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1701；Capecitabine；Oxaliplatin
Description: Radiation: Radiation therapy 50.4Gy in 28 fractions to the pelvis on Days 1-5 every week. Drug: Capecitabine Capecitabine 825mg/m\^2 orally twice daily (bid) 5 days/week during radiotherapy.~Drug:SHR-1701 Drug: Capecitabine (XELOX) Capecitabine 1000mg/m\^2 orally twice daily (bid) day1-day14, q3w. Drug: Oxaliplatin Oxaliplatin 130mg/m\^2, day1, iv, q3w
Study: NCT06128993

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcoronary cooling and dilution
Description: Transcoronary cooling and dilution

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care
Description: Routine clinical care
Study: NCT05603091

Intervention type: PROCEDURE
Intervention: cryoablation of pulmonary veins
Description: Procedures are guided by pressure waveforms analysis, which are obtained by connecting the internal lumen of the catheter through the lateral port of the hemostatic valve attached to the catheter, to a pressure transducer connected in turn to a heparinized saline serum bag and to the cryoablation console.
Study: NCT06419829

Intervention type: OTHER
Intervention: psychoprophylactic program aimed at normalizing body weight through medical training
Description: Based on the assessment of body weight and composition, a 12-week physiophylactic program will be carried out, adapted to the age and gender of the subjects. The program will be carried out twice a week for 30 to 60 minutes (depending on the group). The basis of the program will be the implementation of exercises that reduce fat mass, increase the flexibility and productivity of muscle mass. The classes will be conducted as part of medical training with a training load increasing to at least 85% of HR Max.~The project will include theoretical classes for parents, children and seniors on eating habits, a proper age-appropriate diet, diet changes depending on the subject's health condition and physical activity, and the impact of diet on the process of puberty, adulthood and aging.

Intervention type: OTHER
Intervention: psychoprophylactic program aimed at normalizing body weight through medical training
Description: Based on the assessment of body weight and composition, a 12-week physiophylactic program will be carried out, adapted to the age and gender of the subjects. The program will be carried out twice a week for 30 to 60 minutes (depending on the group). The basis of the program will be the implementation of exercises that reduce fat mass, increase the flexibility and productivity of muscle mass. The classes will be conducted as part of medical training with a training load increasing to at least 85% of HR Max.~The project will include theoretical classes for parents, children and seniors on eating habits, a proper age-appropriate diet, diet changes depending on the subject's health condition and physical activity, and the impact of diet on the process of puberty, adulthood and aging.
Study: NCT04994509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo SC LEN
Description: Administered via SC injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM Oral LEN
Description: Tablets administered orally
Study: NCT04994509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM Oral LEN
Description: Tablets administered orally
Study: NCT04994509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM F/TAF
Description: Tablets administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM F/TDF
Description: Tablets administered orally
Study: NCT05830838

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Image-Guided Adaptive Radiation Therapy
Description: Undergo daily adaptive online replanning for SBRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Image-Guided Adaptive Radiation Therapy
Description: Undergo daily adaptive online replanning for SBRT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study: NCT05270395

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mPal
Description: mPal's patient content includes a multi-component web-based tool with the following: (1) a brief educational video that seeks to educate patients about palliative care; (2) and assessment of palliative care knowledge; (3) assessment of palliative care needs; and (4) an assessment of whether patients would like to meet with palliative care or discuss palliative care and their palliative care needs with their oncology provider.~The provider-level component includes provider education on palliative care. The system-level component includes electronic health record modifications to facilitate palliative care discussions and referrals.
Study: NCT05414409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Metformin is an oral medication that improves insulin sensitivity.
Study: NCT06351527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICP-248
Description: Eligible patients will receive ICP-248 orally as per the protocol
Study: NCT06202235

Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Both CKD Patients and Healthy Volunteers will undergo Magnetic Resonance Elastography (MRE) to evaluate liver and renal viscoelasticity. For CKD patients, blood tests for creatinine and cystatin C, along with blood pressure measurements, will be taken within a three-day window surrounding the MRE test. Additionally, CKD patients will undergo a renal biopsy to assess the extent of fibrosis

Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic Resonance Imaging
Description: Both CKD Patients and Healthy Volunteers will undergo Magnetic Resonance Elastography (MRE) to evaluate liver and renal viscoelasticity. For CKD patients, blood tests for creatinine and cystatin C, along with blood pressure measurements, will be taken within a three-day window surrounding the MRE test. Additionally, CKD patients will undergo a renal biopsy to assess the extent of fibrosis
Study: NCT05251558

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: The telerehabilitation platform is used to deliver the home exercise program.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Education Program
Description: The patient is given education about the points to be considered for the disease and the exercises to be applied.
Study: NCT04876820

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Description: In the intervention arm, the patient meets with the pharmacist. Pharmaceutical intervention (H1) about anti-epileptic drugs prescribed will be done: information on when to take the medication, what to do if you forget to take it or vomit, and an explanation of adverse events. The aim is to improve medication adherence and patient knowledge. A report will be sent to the community pharmacist.~An assessment of medication adherence to antiepileptic drug by MPR at H1 3 months and 6 months (phone call to community pharmacist) will be done. The health insurance score will also be done.~An assessment of patient knowledge by a self-made knowledge questionnaire (10 items) at H1 in pre- post interview -, 3 and 6 months (phone call to patient) will be done.~An assessment of pharmacists' satisfaction about community hospital network by a satisfaction questionnaire will be done.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard of care
Description: An assessment of medication adherence to antiepileptic drug by MPR at the inclusion then 3 months and 6 months later will be done by a phone call to the community pharmacist. An assessment of patient knowledge by a self-made knowledge questionnaire (10 items) at the inclusion then 3 and 6 months later will be done by a phone call to the patient. The health insurance score will be also done during this call.
Study: NCT04751656

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Steady Intervention
Description: Participants will be asked to weigh themselves daily via a smart scale that transmits weight data directly to the study team via the cellular network for 12 months. Every-other week, participants will be sent text messages providing brief feedback encouraging continued self-weighing. Moreover, if a small weight gain is observed, participants will be sent text messages aiming to engage them in commercial or community-based evidence-based weight management resources.
Study: NCT06015178

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intelligent Language Model
Description: Subjects must use the intelligent language model to complete the retrieval and protocol design execution of an interdisciplinary task, in addition to Google search, literature search and book query.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control
Description: Subjects can only use Google search, literature retrieval and book query, and cannot use any AI-driven conversational natural language processing tools to complete the retrieval and protocol design execution of an interdisciplinary task.
Study: NCT04929548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib Maleate Tablets
Description: Addition of Pyrotinib in the EC phase to the standard treatment EC-THP regimen recommended by the guidelines.
Study: NCT05923268

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [99mTc]Tc-G3-(G3S)3C
Description: One single injection of \[99mTc\]Tc-G3-(G3S)3C, followed by gamma camera imaging directly postinjection and after 2, 4, 6 and 24 hours
Study: NCT04604548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral administration of 100 mg KH176 twice daily
Description: Drug: KH176
Study: NCT05609292

Intervention type: DEVICE
Intervention: observational
Description: Infants will get their temperature measured with the liquid crystal thermometer. We are not providing any interventions as they will be in the care of a healthcare team.
Study: NCT06403397

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group: CEASE Care Package and Remember Me Tool
Description: Before the intervention, the intervention group will first undergo the 'Nurse Identification Form' and the 'Alarm Fatigue Scale'. The current root cause analysis of monitor alarms in the clinical setting will be conducted through the 'CEASE Care Package' and the 'Current Situation Analysis Form'. Each patient monitor in the intensive care unit will be observed and recorded by two observers for a period of 24 hours.The Monitor Alarm Control Tool - Remember Me will be attached beneath each monitor to facilitate easier monitoring by nurses. Nurses are expected to use the tool for a period of 15 days. After intervention; Two observers will conduct a re-evaluation using the CEASE Care Package and the Current Status Analysis Form. Monitor alarms will be continuously assessed and recorded for 24 hours. Following the completion of this stage, the Alarm Fatigue Scale will be reapplied to the intervention group.
Study: NCT04882202

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Acetaminophen 1g IV every 6 hours for a weight \> 50kg (maximum of 4g per 24 hours) or 15mg/kg every 6 hours for a weight \< 50kg (maximum of 75mg/kg per 24 hours)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline 100 ml (equal amount of acetaminophen) IV every 6 hours